December 6, 2022
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
July 15, 2022
April 12, 2022
UNC Lineberger’s Susana Garcia-Recio, PhD, and colleagues have identified molecular features responsible for the development and progression of metastatic breast cancer.
January 25, 2022
This is the largest donation in UNC Lineberger’s history, and it enables the cancer center to advance its groundbreaking research on diagnosing and treating a highly aggressive breast cancer that disproportionately affects Black, Latina and young women and historically has limited research funding.
December 10, 2021
Fifteen UNC Lineberger Comprehensive Cancer Center members were named as 2021 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.
December 8, 2021
Charles Perou, PhD, and colleagues have demonstrated a major step forward in melding two key methods for studying breast cancer. This approach enabled them to divide breast cancers into 12 distinct biological groups.
December 3, 2021
Researchers led by Hector L. Franco, PhD, have determined for the first time, cell-by-cell, the genetic and epigenetic state of ovarian and endometrial tumors.
November 9, 2021
August 16, 2021
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
